Navigation Links
The International Rett Syndrome Foundation Names Antony Horton Ph.D. Chief Scientific Officer
Date:6/2/2008

CINCINNATI, June 2 /PRNewswire/ -- The International Rett Syndrome Foundation announced today that Antony Horton Ph.D. will join the Foundation as Chief Scientific Officer, beginning July 1. Dr. Horton will oversee the foundation's research portfolio and its network of Rett Clinics, a series of clinics throughout the US with established neuromedical research and treatment centers. In addition, Dr. Horton will assist the IRSF Board of Directors in growing its funding pool and broadening its network of research partners. IRSF is the world's leading private funder of basic and clinical Rett syndrome research. IRSF was formed in 2007 by the merger of The International Rett Syndrome Association and the Rett Syndrome Research Foundation.

"Dr. Horton joins us during an exciting time for Rett syndrome research since recent breakthroughs give new insight into the function of the MECP2 gene that causes Rett syndrome and last year's discovery of the reversibility of Rett symptoms in mice models," said Kathryn Kissam, IRSF Board Chair. "We have the opportunity to fund crucial new research with the potential to impact lives and advance the understanding of Rett syndrome and related disorders. Dr. Horton's knowledge of the science of drug discovery and his experience in research program management will help the Foundation to shape and advance our mission of improving the lives of children living with Rett while searching for a cure to this devastating disease."

According to Dr. Horton, "As Chief Scientific Officer, I am eager to bring my scientific vision and research management experience to bear on the IRSF mission. I look forward to developing a portfolio of research programs that will accelerate translation of research discoveries into therapies to treat and cure Rett syndrome."

Dr. Horton earned his Ph.D. in developmental neurobiology at St. Andrew's University in Scotland. Currently, Dr. Horton is the Director of Scientific Affairs for the Alzheimer's Drug Discovery Foundation in New York. Previously, he served for several years as Program Director at the Juvenile Diabetes Research Foundation and as a post doctoral scientist at Rockefeller University Laboratory of Molecular Biology.

About Rett Syndrome

While there are over 3,800 known cases of Rett Syndrome in the United States which predominantly strikes only girls, the disorder is genetically linked to more widespread neurological disorders such as autism and schizophrenia. Rett symptoms begin to manifest between the first six to eighteen months of life and in most cases will eventually incapacitate the afflicted children so that they cannot survive without constant care. The disorder causes seizures, respiratory and gastrointestinal abnormalities, and a variety of muscular and motor impairments.

IRSF is the world's most comprehensive non-profit organization dedicated to providing thorough and accurate information about Rett syndrome, offering informational and educational family support, and stimulating research aimed at accelerating treatments and a cure for Rett syndrome. To learn more about IRSF and Rett syndrome, visit http://www.rettsyndrome.org or call IRSF at 1-800-818-RETT.


'/>"/>
SOURCE The International Rett Syndrome Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Thank you to all who ... 8-10. , This event was exclusive to providers and offered an opportunity to ... took place at the Manchester Grand Hyatt where attendees gathered for a lively discussion ...
(Date:3/28/2017)... ... March 28, 2017 , ... Bacteria and fungi are probably not the first ingredients that come ... including the right microorganisms in your diet can actually improve health outcomes. And the good ... is the topic of a new peer-reviewed paper led by Maria Marco, ...
(Date:3/27/2017)... ... March 27, 2017 , ... Drs. Bruce ... makeovers without requiring a referral. Trimble Dental offers a variety of services ... and dental implants. Whether patients have discolored, crooked or missing teeth in Eau ...
(Date:3/27/2017)... ... March 27, 2017 , ... Biotechnology and ... and engagement over the household brands of Top-20 pharma by optimizing clinical trial ... partnering with the right outsourcing payments provider can provide the technology, infrastructure, and ...
(Date:3/27/2017)... ... 27, 2017 , ... SyncDog, Inc. , the leading ... LG Business Solutions at ATARC Federal Mobile Computing Summit , March 28. ... education and examination into the mobility tools and technology employed by the Federal ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Summary This report provides all the information ... and activities since 2010. Description The Partnering Deals and ... partnering activity of one of the world,s leading life sciences ... purchase to ensure inclusion of the most up to date ... delivered in PDF format within 1 working day of receipt ...
(Date:3/27/2017)... -- Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Cryoport" or the "Company") ... common stock in an underwritten public offering under an ... and Exchange Commission (the "SEC"). The offering is subject ... no assurance as to whether or when the offering ... or terms of the offering. Cryoport also expects to ...
(Date:3/27/2017)... , March 27, 2017  A new ... (AADE) found that Medicare,s Competitive Bidding Program (CBP) significantly ... testing supplies. The lack of choice forces beneficiaries to ... have dire health consequences. AADE,s survey ... by AADE and others pointing out the inherent problems ...
Breaking Medicine Technology: